• 53,387+ CME Conference Registrations Sold
  • 160,160+ Medical Conferences
  • 285 Specialties
  • 11,572 Organizers
  • 158,032 Speakers
  • 159 Countries
  • 4,825 Cities
Home  >  Speakers  >  Lamya S. Shihabuddin

Lamya S. Shihabuddin

    MSc, PhD
Head, Senior Scientific Director | Framingham, Massachusetts    United States of America
Neurology
Neurology, Neuroscience,...More
Spoken at 2 events

Biography :

Dr. Lamya S Shihabuddin, is the cluster head of rare neuro- diseases within the Neuroscience Research Therapeutic Area at Sanofi. Dr. Shihabuddin holds an MSc in Neurophysiology from American University of Beirut and Ph.D. in Neuroscience from the University of Miami. She trained as a postdoctoral fellow at The Salk Institute for Biological Studies in La Jolla, where she performed research on the generation of adult derived neural stem cells and potential use for neurodegenerative diseases and spinal cord injury. Dr. Shihabuddin joined Genzyme Corporation in 2000 to work on cell therapies for lysosomal storage diseases and other discovery projects in neurodegenerative diseases.

Since 2006, she has managed the Neuroscience efforts, focusing on rare diseases, at Genzyme Corporation. After becoming part of Sanofi in 2012, Dr. Shihabuddin continues to lead and provide oversight for research efforts focusing on genetically linked and rare neurological diseases.

The efforts of the group are focused on using various therapeutic platforms including small molecule, gene and RNAi therapies for treating rare neurologic diseases including, Amyotrophic lateral sclerosis, Huntington’s disease, Parkinson’s disease, and Rett Syndrome. Dr. Shihabuddin has authored more than 60 scientific articles and book chapters and is a co-author of several patents. She is a member of Society for Neuroscience, Movement Disorder Society, and American Society for Neural transplantation.

**********************
**********
 
For speaker's contact information - Contact us

Specialties

Neurology

Interested Topics

Neurology, Neuroscience, Drug Development, Drug Discovery, Rare Neurological Diseases, Neurodegenerative Diseases, and Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Huntington’s Disease, Parkinson’s Disease, Genetic Neurologic Diseases, Drug Development

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.